Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience.

D'Haene N, Fontanges Q, De Nève N, Blanchard O, Melendez B, Delos M, Dehou MF, Maris C, Nagy N, Rousseau E, Vandenhove J, Gilles A, De Prez C, Verset L, Van Craynest MP, Demetter P, Van Laethem JL, Salmon I, Le Mercier M.

Oncotarget. 2018 Apr 17;9(29):20761-20768. doi: 10.18632/oncotarget.25099. eCollection 2018 Apr 17.

2.

Tumor Surface Regularity at MR Imaging Predicts Survival and Response to Surgery in Patients with Glioblastoma.

Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA, Fernández-Romero A, Luque B, Arregui E, Calvo M, Borrás JM, Meléndez B, Rodríguez de Lope Á, Moreno de la Presa R, Iglesias Bayo L, Barcia JA, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Revert A, Arana E, Pérez-García VM.

Radiology. 2018 Apr 3:171051. doi: 10.1148/radiol.201171051. [Epub ahead of print]

PMID:
29613845
3.

MGMT promoter methylation in Peruvian patients with glioblastoma.

Belmar-Lopez C, Castaneda CA, Castillo M, García-Corrochano P, Orrego E, Meléndez B, Casavilca S, Flores C, Orrego E.

Ecancermedicalscience. 2018 Feb 14;12:812. doi: 10.3332/ecancer.2018.812. eCollection 2018.

4.

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy.

Lyons YA, Pradeep S, Wu SY, Haemmerle M, Hansen JM, Wagner MJ, Villar-Prados A, Nagaraja AS, Dood RL, Previs RA, Hu W, Zhao Y, Mak DH, Xiao Z, Melendez BD, Lizee GA, Mercado-Uribe I, Baggerly KA, Hwu P, Liu J, Overwijk WW, Coleman RL, Sood AK.

Oncotarget. 2017 Aug 24;8(57):96496-96505. doi: 10.18632/oncotarget.20410. eCollection 2017 Nov 14.

5.

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.

Park J, Talukder AH, Lim SA, Kim K, Pan K, Melendez B, Bradley SD, Jackson KR, Khalili JS, Wang J, Creasy C, Pan BF, Woodman SE, Bernatchez C, Hawke D, Hwu P, Lee KM, Roszik J, Lizée G, Yee C.

Cancer Immunol Res. 2017 Aug;5(8):618-629. doi: 10.1158/2326-6066.CIR-17-0051. Epub 2017 Jun 19.

PMID:
28630054
6.

Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line.

de la Rosa J, Sáenz Antoñanzas A, Shahi MH, Meléndez B, Rey JA, Castresana JS.

Tumour Biol. 2016 Sep;37(9):12359-12370. Epub 2016 Jun 15.

PMID:
27306215
7.

P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.

Gallo-Oller G, Vollmann-Zwerenz A, Meléndez B, Rey JA, Hau P, Dotor J, Castresana JS.

Cancer Lett. 2016 Oct 10;381(1):67-75. doi: 10.1016/j.canlet.2016.07.029. Epub 2016 Jul 26.

PMID:
27473823
8.

Trouble at the core: BRAF(V600E) drives multiple modes of T-cell suppression in melanoma.

Bradley SD, Melendez B, Talukder A, Lizée G.

Oncoimmunology. 2015 Aug 25;5(2):e1078966. eCollection 2016 Feb.

9.

Secretory meningioma with KLF4 K409Q mutation in collision with glioma.

Ruiz J, Capilla E, Díaz JF, Ruiz JA, Andrade J, Hernández T, Mollejo M, Meléndez B.

Clin Neuropathol. 2015 Nov-Dec;34(6):322-9. doi: 10.5414/NP300860.

PMID:
26227255
10.

Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.

Torres-Martín M, Kusak ME, Isla A, Burbano RR, Pinto GR, Melendez B, Castresana JS, Rey JA.

Cancer Genet. 2015 Jun;208(6):327-32. doi: 10.1016/j.cancergen.2015.03.012. Epub 2015 Apr 11.

PMID:
25981829
11.

BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.

Bradley SD, Chen Z, Melendez B, Talukder A, Khalili JS, Rodriguez-Cruz T, Liu S, Whittington M, Deng W, Li F, Bernatchez C, Radvanyi LG, Davies MA, Hwu P, Lizée G.

Cancer Immunol Res. 2015 Jun;3(6):602-9. doi: 10.1158/2326-6066.CIR-15-0030. Epub 2015 Mar 20.

12.

Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.

Mur P, Rodríguez de Lope Á, Díaz-Crespo FJ, Hernández-Iglesias T, Ribalta T, Fiaño C, García JF, Rey JA, Mollejo M, Meléndez B.

J Neurooncol. 2015 May;122(3):441-50. doi: 10.1007/s11060-015-1738-9. Epub 2015 Feb 15.

PMID:
25682093
13.

Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.

Mur P, Mollejo M, Hernández-Iglesias T, de Lope ÁR, Castresana JS, García JF, Fiaño C, Ribalta T, Rey JA, Meléndez B.

J Neuropathol Exp Neurol. 2015 Mar;74(3):241-9. doi: 10.1097/NEN.0000000000000167.

PMID:
25668564
14.

Automated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis.

García-Rojo M, Sánchez J, de la Santa E, Durán E, Ruiz JL, Silva A, Rubio FJ, Rodríguez AM, Meléndez B, González L, López-Viedma B.

Diagn Pathol. 2014;9 Suppl 1:S7. doi: 10.1186/1746-1596-9-S1-S7. Epub 2014 Dec 19.

15.

Genome-wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster.

Torres-Martín M, Lassaletta L, de Campos JM, Isla A, Pinto GR, Burbano RR, Melendez B, Castresana JS, Rey JA.

Genes Chromosomes Cancer. 2015 Apr;54(4):197-209. doi: 10.1002/gcc.22232. Epub 2014 Dec 23.

PMID:
25533176
16.

Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples.

Shahi MH, Zazpe I, Afzal M, Sinha S, Rebhun RB, Meléndez B, Rey JA, Castresana JS.

Tumour Biol. 2015 Apr;36(4):2383-91. doi: 10.1007/s13277-014-2846-4. Epub 2014 Nov 22.

17.

Genome-wide microarray expression and genomic alterations by array-CGH analysis in neuroblastoma stem-like cells.

Ordóñez R, Gallo-Oller G, Martínez-Soto S, Legarra S, Pata-Merci N, Guegan J, Danglot G, Bernheim A, Meléndez B, Rey JA, Castresana JS.

PLoS One. 2014 Nov 13;9(11):e113105. doi: 10.1371/journal.pone.0113105. eCollection 2014.

18.

Global expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue.

Torres-Martin M, Lassaletta L, Isla A, De Campos JM, Pinto GR, Burbano RR, Castresana JS, Melendez B, Rey JA.

Oncol Rep. 2014 Dec;32(6):2327-34. doi: 10.3892/or.2014.3526. Epub 2014 Oct 3.

19.

Mycotic popliteal aneurysm rupture secondary to Campylobacter fetus.

Melendez BA, Hollis HW Jr, Rehring TF.

Ann Vasc Surg. 2015 Jan;29(1):122.e9-11. doi: 10.1016/j.avsg.2014.05.021. Epub 2014 Jun 12. Review.

PMID:
24930978
20.

Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component.

Torres-Martín M, Peña-Granero C, Carceller F, Gutiérrez M, Burbano RR, Pinto GR, Castresana JS, Melendez B, Rey JA.

Mol Cytogenet. 2014 Jan 6;7(1):1. doi: 10.1186/1755-8166-7-1.

21.

Effect of pH on technological parameters and physicochemical and texture characteristics of the pasta filata cheese Telita.

Maldonado R, Melendez B, Arispe I, Boeneke C, Torrico D, Prinyawiwatkul W.

J Dairy Sci. 2013;96(12):7414-26. doi: 10.3168/jds.2013-6887. Epub 2013 Oct 11.

PMID:
24119818
22.

Gene expression analysis of aberrant signaling pathways in meningiomas.

Torres-Martín M, Martinez-Glez V, Peña-Granero C, Isla A, Lassaletta L, DE Campos JM, Pinto GR, Burbano RR, Meléndez B, Castresana JS, Rey JA.

Oncol Lett. 2013 Jul;6(1):275-279. Epub 2013 May 23.

23.

Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32.

Torres-Martin M, Lassaletta L, de Campos JM, Isla A, Gavilan J, Pinto GR, Burbano RR, Latif F, Melendez B, Castresana JS, Rey JA.

PLoS One. 2013 Jun 11;8(6):e65868. doi: 10.1371/journal.pone.0065868. Print 2013.

24.

Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors.

Mur P, Mollejo M, Ruano Y, de Lope ÁR, Fiaño C, García JF, Castresana JS, Hernández-Laín A, Rey JA, Meléndez B.

Acta Neuropathol. 2013 Aug;126(2):277-89. doi: 10.1007/s00401-013-1130-9. Epub 2013 May 21.

PMID:
23689617
25.

Gene expression changes associated with erlotinib response in glioma cell lines.

García-Claver A, Lorente M, Mur P, Campos-Martín Y, Mollejo M, Velasco G, Meléndez B.

Eur J Cancer. 2013 May;49(7):1641-53. doi: 10.1016/j.ejca.2013.01.002. Epub 2013 Jan 30.

PMID:
23374632
26.

Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.

Torres-Martin M, Lassaletta L, San-Roman-Montero J, De Campos JM, Isla A, Gavilan J, Melendez B, Pinto GR, Burbano RR, Castresana JS, Rey JA.

Int J Oncol. 2013 Mar;42(3):848-62. doi: 10.3892/ijo.2013.1798. Epub 2013 Jan 24.

27.

Expression analysis of tumor-related genes involved in critical regulatory pathways in schwannomas.

Torres-Martín M, Martinez-Glez V, Peña-Granero C, Lassaletta L, Isla A, de Campos JM, Pinto GR, Burbano RR, Meléndez B, Castresana JS, Rey JA.

Clin Transl Oncol. 2013 May;15(5):409-11. doi: 10.1007/s12094-012-0937-5. Epub 2012 Oct 2.

PMID:
23054753
28.

Genetic alterations associated with progression and recurrence in meningiomas.

Pérez-Magán E, Campos-Martín Y, Mur P, Fiaño C, Ribalta T, García JF, Rey JA, Rodríguez de Lope A, Mollejo M, Meléndez B.

J Neuropathol Exp Neurol. 2012 Oct;71(10):882-93.

PMID:
22964784
29.

Activation of the inflammasome and enhanced migration of microparticle-stimulated dendritic cells to the draining lymph node.

Meraz IM, Melendez B, Gu J, Wong ST, Liu X, Andersson HA, Serda RE.

Mol Pharm. 2012 Jul 2;9(7):2049-62. doi: 10.1021/mp3001292. Epub 2012 Jun 8.

30.

Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death.

Lorente M, Torres S, Salazar M, Carracedo A, Hernández-Tiedra S, Rodríguez-Fornés F, García-Taboada E, Meléndez B, Mollejo M, Campos-Martín Y, Barcia JA, Guzmán M, Velasco G.

Autophagy. 2011 Sep;7(9):1071-3. Epub 2011 Sep 1.

PMID:
21593591
31.

Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression.

de Cárcer G, Escobar B, Higuero AM, García L, Ansón A, Pérez G, Mollejo M, Manning G, Meléndez B, Abad-Rodríguez J, Malumbres M.

Mol Cell Biol. 2011 Mar;31(6):1225-39. doi: 10.1128/MCB.00607-10. Epub 2011 Jan 18.

32.

Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action.

Lorente M, Torres S, Salazar M, Carracedo A, Hernández-Tiedra S, Rodríguez-Fornés F, García-Taboada E, Meléndez B, Mollejo M, Campos-Martín Y, Lakatosh SA, Barcia J, Guzmán M, Velasco G.

Cell Death Differ. 2011 Jun;18(6):959-73. doi: 10.1038/cdd.2010.170. Epub 2011 Jan 14.

33.

Microarray-based comparative genomic hybridization (array-CGH) as a useful tool for identifying genes involved in Glioblastoma (GB).

Ruano Y, Mollejo M, de Lope AR, Hernández-Moneo JL, Martínez P, Meléndez B.

Methods Mol Biol. 2010;653:35-45. doi: 10.1007/978-1-60761-759-4_3. Review.

PMID:
20721736
34.

Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.

Pérez-Magán E, Rodríguez de Lope A, Ribalta T, Ruano Y, Campos-Martín Y, Pérez-Bautista G, García JF, García-Claver A, Fiaño C, Hernández-Moneo JL, Mollejo M, Meléndez B.

Neuro Oncol. 2010 Dec;12(12):1278-90. doi: 10.1093/neuonc/noq081. Epub 2010 Aug 4.

35.

Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma.

Blesa D, Mollejo M, Ruano Y, de Lope AR, Fiaño C, Ribalta T, García JF, Campos-Martín Y, Hernández-Moneo JL, Cigudosa JC, Meléndez B.

J Neuropathol Exp Neurol. 2009 Mar;68(3):274-85. doi: 10.1097/NEN.0b013e31819a3e8c.

PMID:
19225409
36.

Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.

Ruano Y, Ribalta T, de Lope AR, Campos-Martín Y, Fiaño C, Pérez-Magán E, Hernández-Moneo JL, Mollejo M, Meléndez B.

Am J Clin Pathol. 2009 Feb;131(2):257-63. doi: 10.1309/AJCP64YBDVCTIRWV.

PMID:
19141386
37.

Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.

Ruano Y, Mollejo M, Camacho FI, Rodríguez de Lope A, Fiaño C, Ribalta T, Martínez P, Hernández-Moneo JL, Meléndez B.

Cancer. 2008 Apr 1;112(7):1575-84. doi: 10.1002/cncr.23338.

38.

Short communication: Carora cattle show high variability in alpha(s1)-casein.

Caroli A, Chessa S, Chiatti F, Rignanese D, Meléndez B, Rizzi R, Ceriotti G.

J Dairy Sci. 2008 Jan;91(1):354-9.

PMID:
18096958
39.

BCR gene disruption in a pilomyxoid astrocytoma.

Meléndez B, Fiaño C, Ruano Y, Hernández-Moneo JL, Mollejo M, Martinez P.

Neuropathology. 2006 Oct;26(5):442-6.

PMID:
17080723
40.

Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.

Ruano Y, Mollejo M, Ribalta T, Fiaño C, Camacho FI, Gómez E, de Lope AR, Hernández-Moneo JL, Martínez P, Meléndez B.

Mol Cancer. 2006 Sep 26;5:39.

41.

[Hemilingual abscess].

Sánchez-Legaza E, Meléndez B, Miranda Caravallo JI, Pozo Rodríguez M, Murga Tejada C.

An Otorrinolaringol Ibero Am. 2006;33(4):417-23. Spanish.

PMID:
16910398
42.

Identification of amplified and highly expressed genes in amplicons of the T-cell line huT78 detected by cDNA microarray CGH.

Meléndez B, Martínez-Delgado B, Cuadros M, Fernández V, Díaz-Uriarte R, Benítez J.

Mol Cancer. 2005 Jan 18;4(1):5.

43.

Management of urinary tract infections, decubitus ulcer and pneumonia in the aging person.

Ramírez-Ronda CH, Ballesté CR, Meléndez B, Vélez M, Fontán L, Saavedra S, González G.

Bol Asoc Med P R. 2003 Nov-Dec;95(6):42-50.

PMID:
15449791
44.

Gene expression analysis of chromosomal regions with gain or loss of genetic material detected by comparative genomic hybridization.

Meléndez B, Díaz-Uriarte R, Cuadros M, Martínez-Ramírez A, Fernández-Piqueras J, Dopazo A, Cigudosa JC, Rivas C, Dopazo J, Martínez-Delgado B, Benítez J.

Genes Chromosomes Cancer. 2004 Dec;41(4):353-65.

PMID:
15382261
45.

Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.

Martinez-Delgado B, Meléndez B, Cuadros M, Alvarez J, Castrillo JM, Ruiz De La Parte A, Mollejo M, Bellas C, Diaz R, Lombardía L, Al-Shahrour F, Domínguez O, Cascon A, Robledo M, Rivas C, Benitez J.

Clin Cancer Res. 2004 Aug 1;10(15):4971-82.

46.

Antibiotics in older adults.

Rodríguez-Julbe MC, Ramírez-Ronda CH, Arroyo E, Maldonado G, Saavedra S, Meléndez B, González G, Figueroa J.

P R Health Sci J. 2004 Mar;23(1):25-33. Review.

PMID:
15125216
47.

Cystic trigeminal schwannoma with fluid-fluid levels.

Méndez JC, Saucedo G, Meléndez B.

Eur Radiol. 2004 Oct;14(10):1941-3. Epub 2004 Mar 17. No abstract available.

PMID:
15029449
48.

Cloning of a new familial t(3;8) translocation associated with conventional renal cell carcinoma reveals a 5 kb microdeletion and no gene involved in the rearrangement.

Rodríguez-Perales S, Meléndez B, Gribble SM, Valle L, Carter NP, Santamaría I, Conde L, Urioste M, Benítez J, Cigudosa JC.

Hum Mol Genet. 2004 May 1;13(9):983-90. Epub 2004 Mar 11.

PMID:
15016767
49.

Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22-q34 in non-Hodgkin's lymphomas.

Meléndez B, Cuadros M, Robledo M, Rivas C, Fernández-Piqueras J, Martínez-Delgado B, Benítez J.

Leuk Res. 2003 Jul;27(7):627-33.

PMID:
12681362
50.

Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques.

Martínez-Ramírez A, Rodríguez-Perales S, Meléndez B, Martínez-Delgado B, Urioste M, Cigudosa JC, Benítez J.

Cancer Genet Cytogenet. 2003 Mar;141(2):138-42.

PMID:
12606131

Supplemental Content

Loading ...
Support Center